Baptist Health Miami Neuroscience Institute Team Successfully Treats Rare, Disabling Condition - Summary - MDSpire
Feature

Baptist Health Miami Neuroscience Institute Team Successfully Treats Rare, Disabling Condition

Ms. Carrillo was diagnosed with neuromyelitis optica (NMO), a rare autoimmune disease that affects the central nervous system, primarily targeting the optic nerves and spinal cord.

  • April 10, 2026

  • 6 min

Share

Dulima Carrillo, a 57-year-old woman, experienced rapid onset of severe neurological symptoms due to neuromyelitis optica (NMO), an autoimmune disease affecting the central nervous system. After moving to Miami for better care, Dr. Luis Compres-Brugal and Dr. Maria Vera Silva implemented a targeted treatment plan that included inebilizumab therapy. Remarkably, Dulima regained her independence after extensive rehabilitation, emphasizing the importance of early diagnosis and multidisciplinary care in managing rare neurological conditions.

Original Source(s)

Baptist Health Miami Neuroscience Institute Team Successfully Treats Rare, Disabling Condition

  • April 10, 2026

Related Content

Influenza Vaccine Dose and Dementia Outcomes

US claims data compare high- vs standard-dose formulations in patients aged 65 years or more over 3 years of follow-up

Midlife Vitamin D Linked to Lower Tau

Higher vitamin D levels in early midlife were tied to lower tau burden on later brain imaging, while no association was seen with amyloid.

SGLT2 Inhibitors Linked to Lower Epilepsy Risk

Real-world cohort data show lower epilepsy risk vs DPP-4 inhibitors in older patients with type 2 diabetes